SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $326,688 | +45.8% | 2,695 | +55.9% | 0.31% | +201.0% |
Q4 2022 | $224,044 | -48.7% | 1,729 | -70.3% | 0.10% | -49.0% |
Q2 2022 | $437,000 | -51.4% | 5,826 | -41.6% | 0.20% | -56.0% |
Q4 2021 | $899,000 | +162.9% | 9,981 | +367.7% | 0.46% | +99.6% |
Q2 2020 | $342,000 | +1.5% | 2,134 | -18.4% | 0.23% | +31.8% |
Q4 2019 | $337,000 | +81.2% | 2,614 | +5.7% | 0.17% | +183.6% |
Q3 2019 | $186,000 | – | 2,473 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |